Measles vaccine effectiveness in standard and early immunization strategies, Niger, 1995

Pediatric Infectious Disease Journal

Volumn 17, Issue 11, 1998, Pages 1034-1039

  Kaninda, Anne Valérie ^a   Legros, Dominique ^a   Jataou, Idi Moussa ^c   Malfait, Philippe ^a   Maisonneuve, Marc ^b   Paquet, Christophe ^a   Moren, Alain ^a  

^a EPICENTRE   (France)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c NONE

Author keywords

Africa; Developing countries; Epidemic; Immunization schedule; Immunization strategy; Measles; Niger; Outbreak; Vaccine effectiveness

Indexed keywords

MEASLES VACCINE;

ARTICLE; DOSE TIME EFFECT RELATION; EPIDEMIC; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; NIGER; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0031737916     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199811000-00014     Document Type: Article

References (34)

1. WHO, UNICEF. State of the world's vaccines and immunization. Geneva: WHO/GPV 1996.
2. Remme J, Mandara MP, Leeuwenburg J. The force of measles infection in East Africa. Int J Epidemiol 1984;13:332-9.
3. Malfait P, Jataou IM, Jollet MC, Margot A, De Benoist AC, Moren A. Measles epidemic in the urban community of Niamey: transmission patterns, vaccine efficacy and immunization strategies, Niger, 1990 to 1991. Pediatr Infect Dis J 1994;13:38-45.
4. Chen RT, Weierbach R, Bisoffi Z, et al. A "post-honeymoon period' measles outbreak in Muyinga sector, Burundi. Int J Epidemiol 1994;23:185-93.
5. WHO. Expanded Programme on Immunization, Global Advisory Group. Wkly Epidemiol Rec 1981;56:9-15.
6. WHO. Expanded Programme on Immunization. The optimal age for measles immunization. Wkly Epidemiol Rec 1982;57: 89-91.
7. WHO. Expanded Programme on Immunization, Global Advisory Group. Wkly Epidemiol Rec 1989;64:5-12.
8. Markowitz LE, Sepulveda J, Diaz-Ortega JL, et al. Immunization of six-months-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. N Engl J Med 1990;322:580-7.
9. Ndumbe PM, Gilchrist SA, Pabst H, Sama MT, Mbede J. Comparison of Edmonston-Zagreb, Connaught and Schwarz measles vaccines in Cameroonian infants aged 3-8 months. Vaccine 1995;13:276-80.
10. Aaby P. Assumptions and contradictions in measles and measles immunization research: is measles good for something? Soc Sci Med 1995;41:673-86.
11. Burström B, Aaby P, Mutie DM. Measles in infants: a review of studies on incidence, vaccine efficacy and mortality in east Africa. [Review]. East Afr Med J 1995;72:155-61.
12. Rosenthal SR, Clements CJ. Two-dose measles vaccination schedules. Bull WHO 1993;71:421-8.
13. Stetler HC, Orenstein WA, Bernier RH, et al. Impact of revaccinating children who initially received measles vaccine before ten months of age. Pediatrics 1986;77:471-6.
14. Recensement général de la population 1988: résultats préliminaires, Niamey, November, 1990.
15. Smith PG, Rodrigues LC, Fine PEM. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol 1984;13:87-93.
16. Orenstein W.A, Bernier R.H, Hinman A.R. Assessing vaccine efficacy in the field: further observations. Epidemiol Rev 1988;10:212-41.
17. Sahai H, Khurshid A. Statistics in epidemiology: methods, techniques and applications. chaps. 9 and 10. Boca Raton, FL: CRC Press, 1996.
18. Desvé G, Gauët D, Dromer F. L'outil informatique au service de la surveillance. Lett Infectiol 1993;8:376-7.
19. McLean AR, Anderson RM. Measles in developing countries: Part II. the predicted impact of mass vaccination. Epidemiol Infect 1988;100:419-42.
20. Haber M, Orenstein WO, Halloran ME, Longini IM. The effect of disease prior to an outbreak on estimates of vaccine efficacy following the outbreak. Am J Epidemiol 1995;141:980-90.
21. Cutts FT, Smith PG, Colombo S, Mann G, Ascherio A, Soares AC. Field evaluation of measles vaccine efficacy in Mozambique. Am J Epidemiol 1990;131:349-55.
22. Byass P, Adedeji MD, Mongdem JG, Zwandor AC, BrewGraves SH, Clements CJ. Assessment and possible control of endemic measles in urban Nigeria. J Public Health Med 1995;17:140-5.
23. de Quadros CA, Olivé JM, Hersh BS, et al. Measles elimination in the Americas: evolving strategies. JAMA 1996;275:224-9.
24. Williams BG, Cutts FT, Dye C. Measles vaccination policy. Epidemiol Infect 1995;115:603-21.
25. Simba DO, Msamanga GI. Measles vaccine effectiveness under field conditions: a case control study in Tabora region, Tanzania. Trop Geogr Med 1995;47:197-9.
26. Samb B, Aaby P, Whittle HC, et al. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr Infect Dis J 1995;14:203-9.
27. Pabst HF, Spady DW, Marusyk RG, et al. Reduced measles immunity in infants in a well-vaccinated population. Pediatr Infect Dis J 1992;11:525-9.
28. Mulholland K. Measles and pertussis in developing countries with good vaccine coverage. Lancet 1995;345:305-7.
29. Carson MM, Spady DW, Albrecht P, et al. Measles vaccination of infants in a well-vaccinated population. Pediatr Infect Dis J 1995;14:17-22.
30. Markowitz LE, Albrecht P, Rhodes P, et al. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team. Pediatrics 1996;97:53-8.
31. Aaby P, Bukh J, Leerhoy J, Lisse IM, Mordhorst CH, Pedersen IR. Vaccinated children get milder measles infection: a community study from Guinea-Bissau. J Infect Dis 1986;154: 858-63.
32. Taylor WR, Ruti-Kalisa, Mambu ma-Disu, Weinman JM. Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life. Am J Epidemiol 1988;127:788-94.
33. Cutts FT, Henderson RH, Clements CJ, Chen RT, Patriarca PA. Principles of measles control. Bull WHO 1991;69:1-7.
34. Cutts FT. Measles control in young infants: where do we go from here? Lancet 1993;341:290-1.